Publisher: Cognizant Communication Corporation

Related content
Volume 14, Number 6, 1999

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Virus-detected enzyme prodrug therapy using CB1954
pp. 461-472(12)
Authors: Grove, JI; Searle, PF; Weedon, SJ; Green, NK; McNeish, IA; Kerr, DJ

Favourites:Add to Favourites

Antitumour prodrug development using cytochrome P450 (CYP) mediated activation
pp. 473-486(14)
Authors: Patterson, LH; McKeown, SR; Robson, T; Gallagher, R; Raleigh, SM; Orr, S

Favourites:Add to Favourites

Intensely cytotoxic anthracycline prodrugs: galactosides
pp. 507-515(9)
Authors: Bakina, E; Farquhar, D

Favourites:Add to Favourites

Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT)
pp. 517-538(22)
Authors: Niculescu-Duvaz, I; Friedlos, F; Niculescu-Duvaz, D; Davies, L; Springer, CJ

Favourites:Add to Favourites

Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins
pp. 539-548(10)
Authors: Ohsumi, K; Hatanaka, T; Nakagawa, R; Fukuda, Y; Morinaga, Y; Suga, Y; Nihei, Y; Ohishi, K; Akiyama, Y; Tsuji, T

The complete issue is available for purchase

$125.00

Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Add to cart

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more